26427 | yes | testuser | 02/16/2014 11:37:16 AM |
26426 | sdfjlasdfja;dl | testuser | 02/16/2014 11:36:25 AM |
26425 | testing | testuser | 02/16/2014 11:36:16 AM |
26424 | testing | testuser | 02/16/2014 11:36:04 AM |
26423 | testing 32324435454351ddfdf | testuser | 02/16/2014 11:35:55 AM |
26422 | testing 32324435454351 | testuser | 02/16/2014 11:35:48 AM |
26421 | hi for p 2 | testuser | 02/16/2014 11:03:01 AM |
26420 | hi | testuser | 02/15/2014 6:46:30 PM |
26419 | hi | testuser | 02/15/2014 6:44:31 PM |
26418 | hi pal! | testuser | 02/15/2014 6:43:29 PM |
26417 | test post new | itest | 02/15/2014 5:31:57 AM |
26416 | test post | testuser | 02/14/2014 7:26:56 AM |
26415 | reply post | testuser | 02/14/2014 5:41:38 AM |
26414 | test post again | testuser | 02/14/2014 5:41:14 AM |
26413 | test post new | testuser | 02/14/2014 5:18:19 AM |
26412 | test reply | testuser | 02/14/2014 5:10:36 AM |
26410 | admin | testuser | 02/11/2014 11:54:01 PM |
26409 | Test post from testgt | testgt | 02/05/2014 9:34:37 AM |
26408 | test Post | testgt | 02/05/2014 8:10:10 AM |
26407 | New Post | itest | 02/05/2014 7:27:55 AM |
26406 | New test posty | itest | 02/05/2014 4:03:26 AM |
26405 | New post good aftre noon :) | itest | 02/05/2014 3:47:05 AM |
26404 | test post | itest | 02/05/2014 3:37:50 AM |
26403 | New post updates | itest | 02/04/2014 8:05:05 AM |
26401 | new Post | itest | 02/03/2014 7:11:31 AM |
26400 | Nice layout of post :) | itest | 02/03/2014 6:33:14 AM |
26399 | 10 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:13:03 AM |
26398 | 9 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:55 AM |
26396 | 7 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:37 AM |
26395 | 6 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:31 AM |
26391 | 5 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:24 AM |
26390 | 4 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:17 AM |
26389 | 3 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:01 AM |
26388 | 2 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:55 AM |
26387 | 1 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:48 AM |
26386 | thats cool | testuser | 01/31/2014 3:27:17 PM |
26385 | testtt | testuser | 01/31/2014 3:27:04 PM |
26384 | testing | testuser | 01/31/2014 3:26:52 PM |
26382 | If we see half of the volume we saw yesterday, we | Spiceman | 01/31/2014 6:22:10 AM |
26381 | Hi | testuser | 01/23/2014 9:44:55 AM |
26380 | public reply | saurabh | 01/23/2014 8:21:30 AM |
26379 | test post new | saurabh | 01/23/2014 8:20:29 AM |
26378 | asdasdasd // >> | itest | 01/22/2014 1:58:14 AM |
26377 | bolded text | itest | 01/22/2014 1:55:40 AM |
26376 | jbjkkbjbkjbk // >> | itest | 01/22/2014 1:52:00 AM |
26373 | test | testuser | 01/21/2014 9:02:37 PM |
26372 | hi | testuser | 01/17/2014 5:58:57 AM |
26371 | testingnggn | testuser | 01/17/2014 5:58:30 AM |
26366 | test post | itest | 01/17/2014 2:49:35 AM |
26365 | test Post test post | itest | 01/17/2014 12:20:53 AM |
Recent Articles
- James Wynn's Risky Return to High-Leverage Bitcoin Trading
- ProLogic ITS Partners with Signal 8 to Enhance Public Safety
- Unity Software Experiences Stock Surge Following Analyst Upgrade
- Kezar Life Sciences Advances in Autoimmune Hepatitis Trials
- OSE Immunotherapeutics Reveals Recent Liquidity Contract Update
- IPSEN's Recent Buy-Back Activities: Insights and Analysis
- Exosens Expands Night Vision Capabilities Through NVLS Deal
- Investment Growth: What $1000 in RB Global Could Yield
- Zensai's Major Recognition as a Leading AI Innovator
- Investigation Launched: Potential Class Action Against WAMCO
- Guideline Faces Recommendations on 401(k) Claims from NAD
- Chartwells Higher Education Achieves 25 NACUFS Awards in 2025
- AGCO Takes Swift Action to Suspend Licenses of Fergus Bar
- GIGABYTE Unveils New AI PC Models for Enthusiasts and Gamers
- Analyzing the P/E Ratio for First United Inc. Stock Investors
- The Drive Towards Fusion Energy: America's New Manhattan Project
- Primak Construction Group: A Bold New Era for Growth
- Whales Bet Big on Procter & Gamble: What You Should Know
- Revolutionizing Edge AI: SiMa.ai Partners with Cisco
- Analyzing Oscar Health's Stock Movements and Trends
- Tetrate Introduces Agent Router for Enhanced GenAI Flexibility
- Exploring the Recent Trends in American Airlines Options Trading
- Investors Can Join Class Action Against Hims & Hers Health
- United Airlines Earnings: Will Q2 Performance Elevate Stocks?
- Behr Paint and Google Cloud Transform Color Choices with AI
- Exciting Highlights of the 2025 ESL Rochester Fringe Festival
- Empowering Food Security: Fidelis Care's Grant Opportunities
- Federal Signal's Upcoming Earnings Call Brings Excitement
- Investigation of Stock Transactions: TASK, VBTX, TURN Insights
- Investigating Shareholder Rights: OLO and GNTY Sales Reviewed
- BMO Launches Recovery Fund to Support Wildfire Impacted Communities
- JMOON Launches Innovative Facial Toning Device in the USA
- Explore Innovative Opportunities at EmTech MIT 2025
- Charming Cottages Designed by Michael Kramer and Lilly Pulitzer
- JPMorgan Chase's Strong Q2 Results Signal Future Growth
- Exploring the Future of Crypto Mining with EarnMining App
- Exploring the New Frontiers of Live Streaming with Pump.fun
- Echelon Mark Unveils Innovative Web3 and DeFi Training Program
- IPSEN's Strategic Share Buyback Program Insights for Investors
- Cramer's Bold Proposal: Shift Apple from Buybacks to AI Innovation
- Exosens Expands Night Vision Technology with Strategic NVLS Deal
- Investors Under Scrutiny: Legal Probe on Biohaven's Practices
- OSE Immunotherapeutics' Mid-Year Update on Liquidity Initiatives
- PepGen Inc. Faces Legal Investigation Over Investor Claims
- Antimony Resources Drum Up Interest with Recent Drill Program
- AgEagle Aerial Systems Revolutionizes Sugarcane Farming in Brazil
- Investors Alert: Organon Faces Legal Investigation Over Losses
- EIB Enhances Transparency with SEC Form 18-K/A Amendment
- Virbac's Impressive Revenue Growth: An Overview of 2025
- Columbus A/S Modifies 2025 Financial Expectations